Protagonist Therapeutics Inc. (PTGX)
Market Open
3 Mar, 18:46
NASDAQ (NMS) NASDAQ (NMS) Primary 
XBER $
91. 82
-2.42
-2.57%
$
5.76B Market Cap
- P/E Ratio
- Div Yield
0 Volume
0.75 Eps
$ 94.24
Previous Close Day Range
90.02 93.27
Year Range
37.63 96.54
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PTGX earnings report is expected in 15 days (18 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.11 | - |
| | | 0.25 | 1.98 |
| | | - | - |
| | | - | - |
| | | 1.19 | 3.26 |
| | | 1.19 | - |
| | | - | 0.44 |
| | | - | - |
| | | - | - |
| | | - | - |
PTGX Earnings Reports FAQ
What is the earnings per share (EPS) for PTGX?
The current EPS is 0.75.
What is the company's earnings growth rate?
Protagonist Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-18, based on the PTGX's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Protagonist Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PTGX at this time, as Protagonist Therapeutics Inc has no recent EPS data to calculate it.
